You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API docetaxel


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing docetaxel

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sanofi-Aventis US LLC TAXOTERE docetaxel 0075-8003 ALCOHOL
Sanofi-Aventis US LLC TAXOTERE docetaxel 0075-8003 POLYSORBATE 80
Hospira Inc DOCETAXEL docetaxel 0409-0366 ALCOHOL
Hospira Inc DOCETAXEL docetaxel 0409-0366 CITRIC ACID MONOHYDRATE
Hospira Inc DOCETAXEL docetaxel 0409-0366 POLYSORBATE 80
Hospira Inc DOCETAXEL docetaxel 0409-4235 ALCOHOL
Hospira Inc DOCETAXEL docetaxel 0409-4235 CITRIC ACID MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing docetaxel

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc docetaxel 0143-9204 ALCOHOL
Hikma Pharmaceuticals USA Inc docetaxel 0143-9204 ANHYDROUS CITRIC ACID
Hikma Pharmaceuticals USA Inc docetaxel 0143-9204 POLYSORBATE 80
Dr Reddy's Laboratories Inc docetaxel 43598-258 ALCOHOL
Dr Reddy's Laboratories Inc docetaxel 43598-258 ANHYDROUS CITRIC ACID
Dr Reddy's Laboratories Inc docetaxel 43598-258 POLYSORBATE 80
Dr Reddy's Laboratories Inc docetaxel 43598-611 ALCOHOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for docetaxel

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group